PFE dividend yield: 6.77%. CARR dividend yield: 4.00%. Pfizer offers one of the highest dividend yields among blue-chip pharma companies. Post-COVID revenue normalization has pressured earnings, but the dividend has been maintained. Pfizer's acquisition of Seagen adds oncology depth. With 14+ consecutive years of no dividend cuts, income investors see the high yield as an opportunity. CARR is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in CARR shares.
Pfizer offers one of the highest dividend yields among blue-chip pharma companies. Post-COVID revenue normalization has pressured earnings, but the dividend has been maintained. Pfizer's acquisition of Seagen adds oncology depth. With 14+ consecutive years of no dividend cuts, income investors see the high yield as an opportunity.
CARR is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in CARR shares.
Is PFE or CARR better for dividend income in 2026?
PFE currently offers a 6.77% yield (1.68/share/year) while CARR offers 4.00% (2.00/share/year). PFE provides higher current income. However, CARR has grown its dividend faster (5% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in PFE vs CARR earn per year?
With $10,000 invested today: PFE pays approximately $677/year. CARR pays approximately $400/year. With DRIP reinvestment over 10 years, these grow to $5,820/year (PFE) and $899/year (CARR).
Does PFE or CARR pay monthly dividends?
PFE pays quarterly dividends. CARR pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this PFE vs CARR comparison by email
Save your analysis + get weekly dividend insights. Free forever.